Clinical Trial Update: EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-intensity focused ultrasound hemiablation combined with short-term androgen deprivation therapy for prostate cancer control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Institut Mutualiste Montsouris | Conditions: Prostate Cancer, Androgen Deprivation Therapy | Phase 2 | Status: UNKNOWN